Emily Olsen / healthcaredive - The American Hospital Association argues new policies from Eli Lilly and Novo Nordisk requiring providers to submit more claims data on dispensed 340B drugs is onerous and unlawful.
#healthcare #pharmaceuticals #drugpricing #publichealth #governmentpolicy #hospitaloperations #healthcarefinance
Friday, March 6, 2026, 12:23 pm / permalink 20277 / 4 stories in 4 days
Judge orders Leapfrog to remove safety grades for five Florida hospitals (21 hrs)
Daily multivitamin slows epigenetic aging in randomized COSMOS analysis (40 hrs)
White House briefing triggered rapid drops in acetaminophen use in ERs (2 days)
NorthFeed Inc.
Disclaimer: The information provided on this website is intended for general informational purposes only. While we strive for accuracy, we do not guarantee the completeness or reliability of the content. Users are encouraged to verify all details independently. We accept no liability for errors, omissions, or any decisions made based on this information.